GILD
Gilead Sciences Inc
NASDAQ: GILD · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$130.84
+1.55% today
Updated 2026-04-30
Market cap
$159.92B
P/E ratio
19.00
P/S ratio
5.43x
EPS (TTM)
$6.78
Dividend yield
2.44%
52W range
$93 – $156
Volume
6.1M
Gilead Sciences Inc (GILD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.22B | $1.77B | $2.14B | $3.08B | $2.83B | $3.64B | $3.19B | $3.10B | $12.82B | $21.25B | $17.05B | $11.90B | $8.40B | $9.14B | $8.17B | $11.38B | $9.07B | $8.01B | $10.83B | $10.02B |
| Capital expenditures | $105.21M | $78.65M | $115.00M | $230.06M | $61.88M | $131.90M | $397.00M | $190.00M | $557.00M | $747.00M | $748.00M | $590.00M | $924.00M | $825.00M | $650.00M | $579.00M | $728.00M | $585.00M | $523.00M | $563.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $133.83M | $184.60M | $153.36M | $180.68M | $200.04M | $192.38M | $209.00M | $252.00M | $360.00M | $382.00M | $380.00M | $638.00M | $845.00M | $636.00M | $643.00M | $635.00M | $637.00M | $766.00M | $835.00M | $894.00M |
| Free cash flow | $1.11B | $1.69B | $2.03B | $2.85B | $2.77B | $3.51B | $2.80B | $2.92B | $12.26B | $20.50B | $16.30B | $11.31B | $7.48B | $8.32B | $7.52B | $10.80B | $8.34B | $7.42B | $10.30B | $9.46B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $400.00M | $3.12B | $4.66B | $2.36B | $1.73B | $6.38B | $1.87B | $2.46B | $2.73B | $2.97B | $3.22B | $3.45B | $3.60B | $3.71B | $3.81B | $3.92B | $4.00B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-186.34M | $-365.08M | $8.98B | $-8.08B | $309.11M | $7.91B | $2.82B | $-4.62B | $-641.00M | $10.35B | $-6.31B | $-5.68B | $-624.00M | $137.00M | — | — | — |